We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ananda Developments PLC (ANA) ORD GBP0.002

Sell:0.35p Buy:0.40p Change: 0.0045p (1.20%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:0.35p
Buy:0.40p
Change: 0.0045p (1.20%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Sell:0.35p
Buy:0.40p
Change: 0.0045p (1.20%)
Market closed |  Prices as at close on 22 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ananda Developments plc is a United Kingdom-based provider of regulator approved cannabidiol (CBD)-based medicines for chronic pain conditions. The Company's main areas of focus include cannabis cultivation, trials and genetic stabilization work in its wholly owned subsidiary DJT Plants Limited (DJT) and the drug discovery process, clinical trials and market launch of various cannabis based unlicensed medicines via its 100% owned subsidiary MRX Medical Limited (MRX Medical). MRX1, MRX Medical's first product, is to be used in two Phase II Randomized Controlled Trials (RCTs) to investigate the effectiveness of CBD in chemotherapy induced peripheral neuropathy (CIPN) and in patients with endometriosis. MRX1 and MRX2, MRX Medical's second formulation, are launched as unlicensed cannabis-based products for medicinal use in humans (CBPM's). DJT growing method does not use any artificial light or heat. DJT is also undertaking a cannabis sativa genetic stabilization program.

Contact details

Address:
6th Fl
Allianz House, 60 Gracechurch Street
LONDON
EC3V 0HR
United Kingdom
Telephone:
+ (0)
Website:
https://anandadevelopments.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

EPIC:
ANA
ISIN:
GB00BDQPXQ60
Market cap:
£15.96 million
Shares in issue:
2.88 billion
Sector:
Pharmaceuticals
Exchange:
-
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.